Photo of Morgan Schreurs

Morgan Schreurs

Morgan Schreurs helps clients develop and execute public policy strategies, counsels clients through cultural change and political risk, and builds and manages coalitions to accomplish clients’ objectives.

Morgan primarily works with wireless technology, health technology, financial technology, and other companies on public policy matters important to highly regulated industries.

Morgan is a skilled legislative drafter with experience drafting bills and amendments on a wide variety of topics introduced and enacted by the U.S. Congress and state legislatures.

Drawing on her experience in Minnesota State government relations, Morgan co-leads the firm’s state policy practice, advising clients on complex multistate legislative and regulatory policy matters and managing state advocacy efforts.

Morgan is on the forefront of DEI and civil rights issues. As the Policy Director of Invent Together—an alliance of universities, nonprofits, companies, and other stakeholders dedicated to broadening participation in inventing and patenting—she has successfully advocated for the enactment of legislation to close the inventor diversity gaps. She serves on Working Group for the Council for Inclusive Innovation led by the Department of Commerce, as well as the Leadership Advisory Committee of the National Women's Law Center. In addition, Morgan maintains an active pro bono practice focused on matters related to equity and inclusion.

Prior to joining Covington, Morgan worked for the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) under former Ranking Member Patty Murray (D-WA). She also supported federal, state, and local political campaigns and served on the Hillary for America National Advance Team.

As we reported in our prior client advisory on the wave of investigations to follow the pandemic, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act established three new bodies to conduct oversight and investigations on pandemic-related issues. Separately, House Speaker Nancy Pelosi announced a special committee to conduct additional pandemic-related oversight. In recent weeks,

On March 30, 2020, the inspectors general of several major agencies selected the Department of Defense Inspector General, Glenn Fine, to lead a newly created federal oversight entity that will investigate waste, fraud, and abuse in connection with the massive new coronavirus economic relief legislation. The inspectors general were exercising new authority contained in the

Although a final version of the Coronavirus Aid, Relief, and Economic Security (CARES) Act is not yet available, based on what we know so far, it appears that the legislation will include the provisions described below establishing oversight functions for the use of stimulus and bailout funds.  According to a number of sources, the bill

Consistent with popular predictions and our prior posts, Congress made drug pricing a key item on its investigative agenda in the first year of the 116th Congress.  Several factors contributed to the uptick in congressional drug pricing oversight activity, including the elevation of new Democratic chairs in the House with longstanding interests in drug